CH679206A5 - - Google Patents
Download PDFInfo
- Publication number
- CH679206A5 CH679206A5 CH3035/89A CH303589A CH679206A5 CH 679206 A5 CH679206 A5 CH 679206A5 CH 3035/89 A CH3035/89 A CH 3035/89A CH 303589 A CH303589 A CH 303589A CH 679206 A5 CH679206 A5 CH 679206A5
- Authority
- CH
- Switzerland
- Prior art keywords
- percent
- volume
- emulsion
- oxygen
- oil
- Prior art date
Links
- 239000000839 emulsion Substances 0.000 claims description 201
- 108010054147 Hemoglobins Proteins 0.000 claims description 70
- 102000001554 Hemoglobins Human genes 0.000 claims description 70
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 39
- 229910052760 oxygen Inorganic materials 0.000 claims description 39
- 239000001301 oxygen Substances 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 39
- 239000003921 oil Substances 0.000 claims description 38
- 235000019198 oils Nutrition 0.000 claims description 34
- 239000008385 outer phase Substances 0.000 claims description 31
- 239000003995 emulsifying agent Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 27
- 239000003633 blood substitute Substances 0.000 claims description 26
- -1 polyoxyethylene Polymers 0.000 claims description 20
- 239000002480 mineral oil Substances 0.000 claims description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 17
- 239000008158 vegetable oil Substances 0.000 claims description 17
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- 235000010446 mineral oil Nutrition 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 9
- 102000009027 Albumins Human genes 0.000 claims description 8
- 108010088751 Albumins Proteins 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 239000008159 sesame oil Substances 0.000 claims description 8
- 235000011803 sesame oil Nutrition 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 5
- 238000004945 emulsification Methods 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 4
- 235000019485 Safflower oil Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 235000005713 safflower oil Nutrition 0.000 claims description 4
- 239000003813 safflower oil Substances 0.000 claims description 4
- 235000011069 sorbitan monooleate Nutrition 0.000 claims description 4
- 239000001593 sorbitan monooleate Substances 0.000 claims description 4
- 229940035049 sorbitan monooleate Drugs 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000011358 absorbing material Substances 0.000 claims 7
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims 1
- 108010036302 hemoglobin AS Proteins 0.000 claims 1
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 239000012071 phase Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000003860 storage Methods 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 240000006497 Dianthus caryophyllus Species 0.000 description 3
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 3
- 230000007059 acute toxicity Effects 0.000 description 3
- 231100000403 acute toxicity Toxicity 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 229920001993 poloxamer 188 Polymers 0.000 description 3
- 108010050918 polyhemoglobin Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 108010001708 stroma free hemoglobin Proteins 0.000 description 3
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 231100000683 possible toxicity Toxicity 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000640050 Homo sapiens Protein strawberry notch homolog 1 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000004907 Macro-emulsion Substances 0.000 description 1
- 108010061951 Methemoglobin Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 102100033979 Protein strawberry notch homolog 1 Human genes 0.000 description 1
- 241001408665 Timandra griseata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000005147 X-ray Weissenberg Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 108010049645 liposome-encapsulated hemoglobin Proteins 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 108010011424 polyhemoglobin-pyridoxal-5-phosphate Proteins 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- WHOMFKWHIQZTHY-UHFFFAOYSA-N pyridoxine 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(CO)=C1O WHOMFKWHIQZTHY-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/4105—Methods of emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/414—Emulsifying characterised by the internal structure of the emulsion
- B01F23/4144—Multiple emulsions, in particular double emulsions, e.g. water in oil in water; Three-phase emulsions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/922—Colloid systems having specified particle size, range, or distribution, e.g. bimodal particle distribution
- Y10S516/923—Emulsion
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/234,386 US5061688A (en) | 1988-08-19 | 1988-08-19 | Hemoglobin multiple emulsion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH679206A5 true CH679206A5 (https=) | 1992-01-15 |
Family
ID=22881174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH3035/89A CH679206A5 (https=) | 1988-08-19 | 1989-08-18 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US5061688A (https=) |
| JP (1) | JPH02160724A (https=) |
| AU (1) | AU614173B2 (https=) |
| CA (1) | CA1330937C (https=) |
| CH (1) | CH679206A5 (https=) |
| DE (1) | DE3927298C2 (https=) |
| ES (1) | ES2015777A6 (https=) |
| FR (1) | FR2635458B1 (https=) |
| GB (1) | GB2221912B (https=) |
| IT (1) | IT1232170B (https=) |
| NL (1) | NL194665C (https=) |
| SE (1) | SE504671C2 (https=) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061688A (en) * | 1988-08-19 | 1991-10-29 | Illinois Institute Of Technology | Hemoglobin multiple emulsion |
| US5256422A (en) * | 1991-03-28 | 1993-10-26 | Micro Vesicular Systems, Inc. | Lipid vesicle containing water-in-oil emulsions |
| US5622649A (en) * | 1991-06-27 | 1997-04-22 | Emory University | Multiple emulsions and methods of preparation |
| ATE165749T1 (de) * | 1991-06-27 | 1998-05-15 | Univ Emory | Mehrkomponentemulsionen und verfahren zur deren herstellung |
| DE4136699A1 (de) * | 1991-11-07 | 1992-10-22 | Lancaster Group Ag | Verfahren zur herstellung von stabilen, komplexen emulsionssystemen des typs wasser-oel-wasser und deren verwendung als kosmetische praeparate |
| US5670173A (en) * | 1992-09-14 | 1997-09-23 | Mcgill University | Biodegradable polymer membrane containing hemoglobin for blood substitute |
| US6506340B1 (en) | 1993-06-01 | 2003-01-14 | Cobe Cardiovascular, Inc. | Antifoaming device and method for extracorporeal blood processing |
| US5578564A (en) * | 1993-07-23 | 1996-11-26 | Somatogen, Inc. | Nickel-free hemoglobin and methods for producing such hemoglobin |
| US5741893A (en) * | 1993-08-16 | 1998-04-21 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| US5725839A (en) * | 1993-08-16 | 1998-03-10 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI |
| US5824781A (en) * | 1993-08-16 | 1998-10-20 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| US5817632A (en) * | 1993-08-16 | 1998-10-06 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| US5767089A (en) * | 1993-08-16 | 1998-06-16 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| TW381022B (en) | 1993-08-16 | 2000-02-01 | Hsia Jen Chang | Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
| US5840701A (en) * | 1993-08-16 | 1998-11-24 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| US5807831A (en) * | 1993-08-16 | 1998-09-15 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| US5804561A (en) * | 1993-08-16 | 1998-09-08 | Hsia; Jen-Chang | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| DE4341113B4 (de) * | 1993-12-02 | 2006-04-13 | IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG | Stabile multiple X/O/Y-Emulsion |
| DE4343833A1 (de) * | 1993-12-22 | 1995-06-29 | Beiersdorf Ag | W/O/W-Emulsionen |
| US5589177A (en) * | 1994-12-06 | 1996-12-31 | Helene Curtis, Inc. | Rinse-off water-in-oil-in-water compositions |
| US6436969B1 (en) * | 1995-09-12 | 2002-08-20 | Kansas University Medical Center Research Institute Inc. | Dialysis solutions and methods |
| WO1997025978A1 (en) * | 1996-01-15 | 1997-07-24 | BELOYARTSEV, Arkady Felixovich | Method of obtaining perfluorocarbon emulsions for medical purposes |
| US5834519A (en) * | 1996-10-11 | 1998-11-10 | Wayne State University | Stabilized gas-supersaturated emulsions and suspensions |
| US5814601A (en) * | 1997-02-28 | 1998-09-29 | The Regents Of The University Of California | Methods and compositions for optimization of oxygen transport by cell-free systems |
| ATE302019T1 (de) * | 1997-02-28 | 2005-09-15 | Univ California | Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen |
| WO1999043301A1 (en) * | 1998-02-24 | 1999-09-02 | The Board Of Trustees Of The University Of Illinois | Lipid emulsions in the treatment of systemic poisoning |
| EP1038573B1 (en) * | 1999-03-19 | 2005-12-14 | Kao Corporation | Process for preparing emulsion |
| US6500809B1 (en) | 1999-11-12 | 2002-12-31 | Neuron Therapeutics, Inc. | Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| US6777450B1 (en) * | 2000-05-26 | 2004-08-17 | Color Access, Inc. | Water-thin emulsions with low emulsifier levels |
| DE10034970B4 (de) * | 2000-07-19 | 2004-11-18 | Sanguibiotech Gmbh | Einen Sauerstoffträger, ausgewählt aus Hämoglobin oder Hämoglobin- und Myoglobin-enthaltende Zubereitung in Form einer Emulsion sowie deren Verwendung als kosmetisches Externum und zur natürlichen Regeneration der Haut bei Sauerstoff-Mangel |
| US7008535B1 (en) | 2000-08-04 | 2006-03-07 | Wayne State University | Apparatus for oxygenating wastewater |
| US6747132B2 (en) | 2000-11-29 | 2004-06-08 | Apex Biosciences, Inc. | Methods for the synthesis of a modified hemoglobin solution |
| EP1372573B1 (en) * | 2001-03-21 | 2009-10-07 | Madash LLC | Thermally reversible water in oil in water emulsions |
| JP2004538264A (ja) | 2001-04-18 | 2004-12-24 | ノースフィールド ラボラトリーズ | 安定化ヘモグロビン溶液の保管のための可撓性容器システム |
| US20050164915A1 (en) * | 2002-04-01 | 2005-07-28 | Sangart, Inc. | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| US20030153491A1 (en) * | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| DE10209860A1 (de) * | 2002-03-06 | 2003-09-25 | Hemofarm Konzern A D | Hydrophobe Nanotropfen mit gebundenen Hämoglobinmolekülen in hydrophiler Phase enthaltene Emulsion als Blutersatzstoff |
| JP3912206B2 (ja) * | 2002-07-05 | 2007-05-09 | 株式会社日立製作所 | 筒内直接燃料噴射装置用燃料ポンプ |
| US20040072729A1 (en) * | 2002-10-10 | 2004-04-15 | Sunbio Inc. | High oxygen affinity PEG-hemoglobin as treatment for brain stroke |
| US7803365B2 (en) * | 2002-12-02 | 2010-09-28 | Biovec, Llc | Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| US9388427B2 (en) * | 2002-12-02 | 2016-07-12 | Biovec, Llc | In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| US7135553B2 (en) * | 2003-01-29 | 2006-11-14 | Northfield Laboratories, Inc. | Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| CA2515916A1 (en) * | 2003-02-25 | 2004-09-10 | Biovec B.V. | Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| US20050186183A1 (en) * | 2003-12-08 | 2005-08-25 | Deangelo Joseph | Stabilized products, processes and devices for preparing same |
| US7087369B2 (en) * | 2003-12-17 | 2006-08-08 | The Regents Of The University Of California | Cornea preservation medium |
| ES2375115T3 (es) * | 2005-03-31 | 2012-02-24 | Suntory Holdings Limited | Emulsión de aceite en agua que contiene un compuesto de lignano y composición que comprenden al mismo. |
| CN1733298B (zh) * | 2005-08-16 | 2011-08-24 | 华东理工大学 | 血红蛋白为基础的微囊型血液代用品及其制备方法 |
| US20070196810A1 (en) * | 2006-01-24 | 2007-08-23 | Northfield Laboratories Inc. | Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells |
| US20090004159A1 (en) * | 2006-01-24 | 2009-01-01 | The Board Of Trustees Of The University Of Illinoi | Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
| KR101425241B1 (ko) * | 2006-10-04 | 2014-08-01 | 산토리 홀딩스 가부시키가이샤 | 리그난류 화합물 함유 ｏ/ｗ/ｏ형 에멀션 및 그것을 함유하는 조성물 |
| US8906855B2 (en) | 2007-12-22 | 2014-12-09 | Vivacelle Bio, Inc. | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| US8618056B2 (en) | 2007-12-22 | 2013-12-31 | Cuthbert O. Simpkins | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| US8063020B2 (en) * | 2007-12-22 | 2011-11-22 | Simpkins Cuthbert O | Resuscitation fluid |
| WO2010017459A1 (en) | 2008-08-07 | 2010-02-11 | Bioactive Surgical, Inc> | Stem cell capture and immobilization coatings for medical devices and implants |
| CN102300555B (zh) * | 2009-01-30 | 2015-06-17 | 卡斯伯特·O·辛普金斯 | 复苏液 |
| EP2430109A4 (en) * | 2009-04-28 | 2016-01-06 | Israel State | EMULSIONS, EMULSIFIER, METHOD OF USE AND METHOD OF MANUFACTURE |
| US8273857B2 (en) * | 2009-09-22 | 2012-09-25 | Jen-Chang Hsia | Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine |
| DE102011118500A1 (de) * | 2011-11-15 | 2013-05-16 | Planaturo GmbH & Co. KG | Vegane Emulsion |
| EP3212315A4 (en) | 2014-10-31 | 2018-07-11 | Massachusetts Institute of Technology | Compositions and methods for forming emulsions |
| US11119098B2 (en) | 2014-10-31 | 2021-09-14 | Massachusetts Institute Of Technology | Systems including Janus droplets |
| US10238739B2 (en) | 2014-12-02 | 2019-03-26 | Novartis Ag | Manufacture of surfactant-containing compositions with enhanced stability |
| US20190170737A1 (en) | 2016-09-19 | 2019-06-06 | Massachusetts Institute Of Technology | Systems including janus droplets |
| EP4529951A3 (en) | 2017-01-08 | 2025-05-28 | The United States Government as Represented by the Department of Veterans Affairs | Methods for decreasing injuries associated with intraoperative hypotension |
| US12274993B2 (en) | 2019-09-18 | 2025-04-15 | Massachusetts Institute Of Technology | Systems and methods for affecting interactions of electromagnetic radiation with janus droplets for sensitive detection of species |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3823091A (en) * | 1971-05-19 | 1974-07-09 | Green Cross Corp | Stable emulsion of fluorocarbon particles |
| US3823901A (en) * | 1973-07-24 | 1974-07-16 | Us Navy | Aerial launch system |
| US3993581A (en) * | 1973-10-05 | 1976-11-23 | The Green Cross Corporation | Process for preparing stable oxygen transferable emulsion |
| US4146499A (en) * | 1976-09-18 | 1979-03-27 | Rosano Henri L | Method for preparing microemulsions |
| US4390521A (en) * | 1980-04-11 | 1983-06-28 | Exxon Research And Engineering Co. | Artificial red cells |
| US4376059A (en) * | 1980-04-11 | 1983-03-08 | Exxon Research And Engineering Co. | Process for preparing artificial red cells |
| US4569784A (en) * | 1980-11-17 | 1986-02-11 | Adamantech, Inc. | Preparation of a gel having gas transporting capability |
| US4533254A (en) * | 1981-04-17 | 1985-08-06 | Biotechnology Development Corporation | Apparatus for forming emulsions |
| US4461717A (en) * | 1982-03-19 | 1984-07-24 | Sun Tech, Inc. | Stable gas-carrying compositions |
| US4425334A (en) * | 1982-04-02 | 1984-01-10 | The Regents Of The University Of California | Functional oxygen transport system |
| US4612370A (en) * | 1982-04-02 | 1986-09-16 | The Regents Of The University Of California | Lipid-saccharide reaction products |
| WO1984001270A1 (fr) * | 1982-10-01 | 1984-04-12 | Meiji Milk Prod Co Ltd | Procede de production de compositions alimentaires d'huile et de graisse a emulsion eau/huile/eau |
| JPS60183031A (ja) * | 1984-03-02 | 1985-09-18 | Meiji Milk Prod Co Ltd | Ｗ／ｏ／ｗ型複合エマルジヨンの製造法 |
| FR2589160B1 (fr) * | 1985-10-29 | 1988-01-08 | Elf France | Composition d'hydrocarbures lourds a viscosite abaissee sous forme d'emulsion multiple, et procede pour sa preparation |
| US4865836A (en) * | 1986-01-14 | 1989-09-12 | Fluoromed Pharmaceutical, Inc. | Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
| US4808334A (en) * | 1986-07-11 | 1989-02-28 | Fuji Oil Company, Ltd. | Production of sterile composite emulsion |
| US4776991A (en) * | 1986-08-29 | 1988-10-11 | The United States Of America As Represented By The Secretary Of The Navy | Scaled-up production of liposome-encapsulated hemoglobin |
| JPH01503146A (ja) * | 1986-09-19 | 1989-10-26 | ケメックス ファーマシューティカルズ，インコーポレイティド | 身体組織の治療方法および身体組織への医薬の投与方法 |
| US4866096A (en) * | 1987-03-20 | 1989-09-12 | Air Products And Chemicals, Inc. | Stable fluorochemical aqueous emulsions |
| US5061688A (en) * | 1988-08-19 | 1991-10-29 | Illinois Institute Of Technology | Hemoglobin multiple emulsion |
-
1988
- 1988-08-19 US US07/234,386 patent/US5061688A/en not_active Expired - Fee Related
-
1989
- 1989-08-18 SE SE8902773A patent/SE504671C2/sv not_active IP Right Cessation
- 1989-08-18 CH CH3035/89A patent/CH679206A5/de not_active IP Right Cessation
- 1989-08-18 DE DE3927298A patent/DE3927298C2/de not_active Expired - Fee Related
- 1989-08-18 ES ES8902899A patent/ES2015777A6/es not_active Expired - Lifetime
- 1989-08-18 CA CA000608778A patent/CA1330937C/en not_active Expired - Fee Related
- 1989-08-18 GB GB8918880A patent/GB2221912B/en not_active Expired - Lifetime
- 1989-08-19 JP JP1214018A patent/JPH02160724A/ja active Pending
- 1989-08-21 NL NL8902100A patent/NL194665C/nl not_active IP Right Cessation
- 1989-08-21 AU AU40086/89A patent/AU614173B2/en not_active Ceased
- 1989-08-21 FR FR898911078A patent/FR2635458B1/fr not_active Expired - Fee Related
- 1989-08-21 IT IT8948297A patent/IT1232170B/it active
-
1991
- 1991-10-11 US US07/776,062 patent/US5217648A/en not_active Expired - Fee Related
-
1993
- 1993-03-03 US US08/025,608 patent/US5438041A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3927298A1 (de) | 1990-03-01 |
| JPH02160724A (ja) | 1990-06-20 |
| AU4008689A (en) | 1990-02-22 |
| US5217648A (en) | 1993-06-08 |
| DE3927298C2 (de) | 2003-02-06 |
| IT1232170B (it) | 1992-01-25 |
| SE504671C2 (sv) | 1997-03-24 |
| NL194665C (nl) | 2002-11-04 |
| GB2221912B (en) | 1992-09-23 |
| FR2635458A1 (fr) | 1990-02-23 |
| NL8902100A (nl) | 1990-03-16 |
| CA1330937C (en) | 1994-07-26 |
| ES2015777A6 (es) | 1990-09-01 |
| SE8902773L (sv) | 1990-02-20 |
| AU614173B2 (en) | 1991-08-22 |
| IT8948297A0 (it) | 1989-08-21 |
| US5061688A (en) | 1991-10-29 |
| FR2635458B1 (fr) | 1994-11-18 |
| SE8902773D0 (sv) | 1989-08-18 |
| GB2221912A (en) | 1990-02-21 |
| GB8918880D0 (en) | 1989-09-27 |
| US5438041A (en) | 1995-08-01 |
| NL194665B (nl) | 2002-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3927298C2 (de) | Mehrfachemulsion und Verfahren zu ihrer Herstellung | |
| DE3785054T2 (de) | Stabile emulsionen von stark fluorierten, organischen verbindungen. | |
| DE3790322C2 (de) | Nichtzellulares Präparat als Ersatz für rote Blutkörperchen | |
| DE3786555T2 (de) | Vermehrte herstellung von mit liposomen eingekapseltem hämoglobin. | |
| DE69126861T2 (de) | Lösung zur aufbewahrung roter blutzellen | |
| DE3326901C2 (https=) | ||
| DE2834308C2 (de) | Verfahren zur Wasserabspaltung aus einer kolloidalen Liposomen-Dispersion | |
| DE69433933T2 (de) | Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen | |
| DE69220064T2 (de) | Zusammensetzungen, die einen fluorokohlenwasserstoff und eine lipophile/fluorophile organische verbindung enthalten und ihre verwendungen | |
| DE3144705C2 (de) | Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat | |
| DE3145625A1 (de) | Gelzusammensetzung und verfahren zu ihrer herstellung | |
| DE2601207B2 (de) | Verfahren zur Herstellung einer flüssigen pharmazeutischen Zubereitung mit gesteuertem Arzneimittelabgabevermögen | |
| EP0071888A2 (de) | Verfahren zur Gewinnung von hepatitissicheren, sterilen, pyrogenfreien und stromafreien Hämoglobinlösungen | |
| US4532130A (en) | Preparation of synthetic frythrocytes | |
| DE2630586C2 (de) | Wäßrige Emulsion auf Basis Perfluorkohlenstoffverbindungen, Verfahren zu ihrer Herstellung und deren Verwendung als Blutersatzmittel und Perfusionsflüssigkeit | |
| DE2248475C3 (de) | Verfahren zur Gewinnung von hepatitissicheren, lagerungsstabilen und infundierbaren Hämoglobinlösungen | |
| DE2144094C3 (de) | Verfahren zur Herstellung einer zum Sauerstofftransport befähigten, injizierbaren Fluorkohlenstoffteilchenemulsion | |
| DE10351644A1 (de) | Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen | |
| EP1095659B1 (de) | Celluloseether stabilisierte Öl-in-Wasser Emulsionen als Träger für homöopathische und pflanzliche Wirkstoffe | |
| EP0082877A1 (en) | Preparation of synthetic erythrocytes | |
| EP0685492B1 (de) | Verfahren zur Herstellung molekulareinheitlicher hyperpolymerer Hämoglobine | |
| DE4111939A1 (de) | Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels | |
| EP1480614B1 (de) | Hydrophobe nanotropfen mit gebundenen hämoglobinmolekülen in hydrophiler phase enthaltende emulsion als blutersatzstoff | |
| JPS6379826A (ja) | 静脈注射用脂肪乳剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |